William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 32,446 shares at $96.04 ($3.1M) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Open-market sale of $3.1M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.04 | 16,223 | $1.6M | 50.0% |
| 2 | $96.04 | 16,223 | $1.6M | 50.0% |
| Total | $96.04 avg | 32,446 | $3.1M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |